This is a monthly publication targeting identified problematic therapeutic issues (brief, simple, practical messages). The process involves a literature review and development of the message by different working groups of the Therapeutics Initiative. A draft of the Letter is circulated for comment among specialists who are expert in the particular therapeutic area and all members and associates of the Therapeutics Initiative before the Letter is finalized and disseminated.
The Therapeutics Letter is a member of the International Society of Drug Bulletins (ISDB), a world-wide network of independent drug bulletins that aims to promote international exchange of quality information on drugs and therapeutics.
ISSN: 2369-8691 (Online)
ISSN: 2369-8683 (Print)